Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma
Journal for ImmunoTherapy of Cancer · 2025-11 · 13 (11) · e012860
DOI: 10.1136/jitc-2025-012860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 11.11.2025. Verfasst von Ombretta Melaiu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Neuroblastoma, Tertiary Lymphoid Structures, B-Lymphocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Associazione Italiana Ricerca sul Cancro, European Union’s Horizon 2020 research and Innovation program under the Marie Skłodowska-Curie Actions, Italian Ministry of Health.
Abstract (Originalsprache)
Background
Immunotherapy has transformed cancer treatment, highlighting the importance of effective antitumor immunity to fight cancer. However, its success in pediatric cancer remains limited, underscoring the urgent need to identify new immunotherapeutic targets. In this study, we explored the clinical relevance of B cells and tertiary lymphoid structures (TLS) in neuroblastoma (NB), a pediatric tumor with a heterogeneous immune landscape.
Methods
We analyzed 87 treatment-naïve NB specimens, spanning both localized and metastatic disease previously characterized for T-cell and dendritic cell (DC) infiltration. B cells were detected by immunohistochemistry, and plasma cells were quantified using multiple immunofluorescence. Spatial organization and functional status of immune cells within TLSs were assessed by imaging mass cytometry using a 29-antibody panel. In parallel, gene expression profiles were obtained through NanoString PanCancer Immune Profiling and further validated using publicly available bulk and single-cell RNA-sequencing data from untreated and treated NB samples. These transcriptomic datasets were used to support protein-level findings and to identify prognostic gene signatures.
Results
B-cell infiltration in NB tumors strongly correlated with the presence of T cells and DCs at both protein and transcriptomic levels, and was associated with improved prognosis. Similar to other solid tumors, B cells in NB were either scattered throughout the tumor or organized into TLSs of varying maturity. Spatial proteomic and transcriptomic analyses revealed that localized tumors often contain mature TLSs, with functional B cells able to antigen presentation and immunoglobulin expression, alongside high cytotoxic T cells. In contrast, metastatic tumors primarily exhibited immature TLSs, with evidence of B-cell and T-cell dysfunction. Importantly, we identified gene signatures associated with B cells and TLSs that not only predicted survival in NB but were also prognostic in multiple adult cancers.
Conclusions
Our findings highlight a central role for B cells and TLSs in shaping the immune microenvironment of NB. Their presence and maturation status are linked to clinical outcome, suggesting their potential as prognostic biomarkers and targets for novel immunotherapeutic strategies in pediatric oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
- Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy.
- Data Science for Health, Fondazione Bruno Kessler Research Center, Trento, Italy.
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
- Division of Pediatric Oncology and Pediatric Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.
Förderung
- Associazione Italiana Ricerca sul Cancro
- European Union’s Horizon 2020 research and Innovation program under the Marie Skłodowska-Curie Actions
- Italian Ministry of Health
Zitieren
APA
Melaiu, O., Chierici, M., Gragera, P., Lazzaro, N., Petrilli, L. L., Wienke, J., Bergsma, F. J., Verhoeven, B. M., De Stefanis, C., D'Oria, V., Benedetti, M. C., Barillari, G., Alaggio, R., De Ioris, M. A., Vinci, M., Baryawno, N., Carsetti, R., Jurman, G., Molenaar, J. J., …, & Fruci, D. (2025). Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma. Journal for ImmunoTherapy of Cancer, 13(11), e012860. https://doi.org/10.1136/jitc-2025-012860
Vancouver
Melaiu O, Chierici M, Gragera P, Lazzaro N, Petrilli LL, Wienke J, et al. Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma. Journal for ImmunoTherapy of Cancer. 2025;13(11):e012860. doi:10.1136/jitc-2025-012860
BibTeX
@article{Melaiu2025,
author = {Melaiu, Ombretta and Chierici, Marco and Gragera, Paula and Lazzaro, Nicolò and Petrilli, Lucia L and Wienke, Judith and Bergsma, Francisca J and Verhoeven, Bronte Manouk and De Stefanis, Cristiano and D'Oria, Valentina and Benedetti, Maria C and Barillari, Giovanni and Alaggio, Rita and De Ioris, Maria Antonietta and Vinci, Maria and Baryawno, Ninib and Carsetti, Rita and Jurman, Giuseppe and Molenaar, Jan J and Locatelli, Franco and Fruci, Doriana},
title = {Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
volume = {13},
number = {11},
pages = {e012860},
doi = {10.1136/jitc-2025-012860}
}
EUVIMED